Sarah Barton
Sutton Upon Derwent, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Proton pump inhibition to prevent delayed chemotherapy-induced nausea and vomiting in patients receiving adjuvant or neoadjuvant breast cancer chemotherapy: a phase II, randomised double-blind crossover trial (PantoCIN).
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 29, 2024
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial.
Journal: Annals of hematology
Published: September 09, 2019
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial.
Journal: Oncotarget
Published: November 27, 2015
The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 01, 2015
Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma.
Journal: European journal of haematology
Published: July 09, 2014
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.
Journal: Annals of hematology
Published: May 16, 2013
Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?
Journal: The oncologist
Published: October 23, 2012
Recent developments in treatment stratification for metastatic breast cancer.
Journal: Drugs
Published: November 01, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026